Management of Human Coronavirus HKU1 in Hospitalized Patients
Primary Recommendation
There is no specific antiviral treatment for human coronavirus HKU1 infection; management consists entirely of supportive care with oxygen therapy as the primary intervention, similar to other mild-to-moderate respiratory viral infections. 1, 2, 3
Clinical Context and Disease Severity
Human coronavirus HKU1 is one of the four endemic human coronaviruses (along with 229E, OC43, and NL63) that typically cause mild, self-limiting upper respiratory tract infections like the common cold. 4, 2, 3 However, HKU1 can cause severe respiratory illness requiring hospitalization in adults:
- In one U.S. cohort, 54% of HKU1-positive adults required hospitalization, with 71% of hospitalized patients needing supplemental oxygen and 29% requiring ICU admission. 1
- Median length of hospitalization was 5 days. 1
- The infection can be fatal, particularly in patients with underlying conditions. 1
Supportive Care Management
Oxygen Therapy
- Provide supplemental oxygen to maintain SpO2 ≥94% on room air for patients with hypoxemia. 1
- Monitor oxygen saturation at least twice daily. 5
- Target SpO2 no higher than 96% if supplemental oxygen becomes necessary. 5
Respiratory Monitoring
- Monitor respiratory rate at least twice daily, as this is often the earliest sign of deterioration before oxygen desaturation occurs. 5
- Watch for increased work of breathing and signs of respiratory distress. 5
Advanced Respiratory Support
- For patients with hypoxemic respiratory failure, consider high-flow nasal cannula (HFNC) or noninvasive CPAP if they do not have immediate indication for invasive mechanical ventilation. 6, 7
- Perform tracheal intubation and invasive mechanical ventilation promptly if patients do not improve or worsen within 1-2 hours on noninvasive support. 6
What NOT to Do
Avoid Inappropriate Antibiotic Use
- Do not routinely prescribe antibiotics unless there is documented bacterial coinfection or strong clinical suspicion of bacterial superinfection. 6, 5 Despite this recommendation, 62% of HKU1-positive adults in one study received antibiotics unnecessarily. 1
Avoid Corticosteroids
- Do not administer corticosteroids to patients with HKU1 infection who do not require supplemental oxygen, as this provides no mortality benefit and causes harm. 6, 7, 5 Note that 38% of HKU1-positive adults in one study were using inhaled steroids, which may have been a risk factor. 1
No Specific Antivirals Available
- There are no specific antiviral drugs recommended or proven effective for HKU1 infection. 2, 3
- Do not use hydroxychloroquine, lopinavir-ritonavir, or other antivirals empirically, as these have no proven benefit for endemic coronavirus infections. 6, 7, 5
Infection Control Measures
- Implement standard respiratory precautions with appropriate PPE for healthcare workers. 6
- Use spatial control with designated "risk" and "clean" zones to prevent cross-contamination. 6
- Examine confirmed HKU1 patients last in the daily schedule to minimize exposure risk. 6
- Use dedicated medical equipment for infected patients. 6
Special Considerations
Risk Factors to Monitor
- History of smoking (85% of HKU1-positive adults in one study were smokers). 1
- Use of inhaled corticosteroids (38% in one study). 1
- Presence of gastrointestinal symptoms (38% reported GI symptoms in addition to respiratory symptoms). 1
Coinfection Assessment
- Check for viral coinfections, particularly influenza, which was detected in 15% of HKU1-positive adults. 1
- Perform appropriate infectious workup if clinical deterioration occurs despite supportive care. 1
Discharge Criteria
Patients can be discharged when they meet all of the following:
- Temperature returned to normal for more than 3 days. 6
- Respiratory symptoms significantly improved. 6
- No longer requiring supplemental oxygen with stable SpO2 ≥94% on room air. 6
Critical Pitfalls to Avoid
- Do not delay recognition of deterioration—respiratory rate elevation and increased work of breathing often precede oxygen desaturation. 5
- Do not delay intubation when noninvasive respiratory support fails or signs of exhaustion appear. 5
- Do not prescribe antibiotics reflexively without evidence of bacterial infection. 6, 5, 1
- Do not use corticosteroids in non-hypoxic patients with HKU1 infection. 6, 7, 5